Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

383 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Higher exercise tolerance early after allogeneic hematopoietic stem cell transplantation is the predictive marker for higher probability of later social reintegration.
Hamada R, Arai Y, Kondo T, Harada K, Murao M, Miyasaka J, Yoshida M, Yonezawa H, Nankaku M, Ouchi S, Kitakubo W, Wadayama T, Kanda J, Takaori-Kondo A, Ikeguchi R, Matsuda S. Hamada R, et al. Among authors: yonezawa h. Sci Rep. 2021 Mar 30;11(1):7190. doi: 10.1038/s41598-021-86744-8. Sci Rep. 2021. PMID: 33785825 Free PMC article.
Analysis of factors associated with patient-reported physical functioning scores at discharge of allogeneic hematopoietic stem cell transplantation patients: a cross-sectional study.
Murao M, Hamada R, Kondo T, Miyasaka J, Yoshida M, Yonezawa H, Arai Y, Kanda J, Nankaku M, Ikeguchi R, Takaori-Kondo A, Matsuda S. Murao M, et al. Among authors: yonezawa h. Support Care Cancer. 2021 Dec;29(12):7569-7576. doi: 10.1007/s00520-021-06323-5. Epub 2021 Jun 12. Support Care Cancer. 2021. PMID: 34120260 Free article.
Evaluation of indices for predicting recovery of exercise tolerance in patients surviving allogenic hematopoietic stem cell transplantation.
Hamada R, Kondo T, Harada K, Murao M, Miyasaka J, Yoshida M, Yonezawa H, Nankaku M, Arai Y, Kanda J, Takaori-Kondo A, Ikeguchi R, Matsuda S. Hamada R, et al. Among authors: yonezawa h. Support Care Cancer. 2022 May;30(5):4027-4034. doi: 10.1007/s00520-022-06822-z. Epub 2022 Jan 22. Support Care Cancer. 2022. PMID: 35066668 Free article.
IMU1003, an atrarate derivative, inhibits Wnt/β-catenin signaling.
Yonezawa H, Sugawara A, Sakyo T, Uehara Y, Kawano T, Nishiya N. Yonezawa H, et al. Biochem Biophys Res Commun. 2020 Nov 12;532(3):440-445. doi: 10.1016/j.bbrc.2020.08.031. Epub 2020 Sep 3. Biochem Biophys Res Commun. 2020. PMID: 32891433
Lamellarin 14, a derivative of marine alkaloids, inhibits the T790M/C797S mutant epidermal growth factor receptor.
Nishiya N, Oku Y, Ishikawa C, Fukuda T, Dan S, Mashima T, Ushijima M, Furukawa Y, Sasaki Y, Otsu K, Sakyo T, Abe M, Yonezawa H, Ishibashi F, Matsuura M, Tomida A, Seimiya H, Yamori T, Iwao M, Uehara Y. Nishiya N, et al. Among authors: yonezawa h. Cancer Sci. 2021 May;112(5):1963-1974. doi: 10.1111/cas.14839. Epub 2021 Mar 24. Cancer Sci. 2021. PMID: 33544933 Free PMC article.
383 results